Biology and treatment of Burkitt's lymphoma

@article{Yustein2007BiologyAT,
  title={Biology and treatment of Burkitt's lymphoma},
  author={J. Yustein and C. Dang},
  journal={Current Opinion in Hematology},
  year={2007},
  volume={14},
  pages={375–381}
}
  • J. Yustein, C. Dang
  • Published 2007
  • Biology, Medicine
  • Current Opinion in Hematology
    • Purpose of reviewBurkitt's lymphoma is a unique hematological malignancy remarkable for its biological characteristics, including aberrant expression of the MYC oncogene, and its requirement for intensive treatment regimens. This review will focus on those features, and discuss recent advances in the molecular biology and advancing treatment options for the disease. Recent findingsAdvances in molecular biology have provided many new insights into the biology and treatment options for Burkitt's… CONTINUE READING
    View on Wolters Kluwer
    ncbi.nlm.nih.gov
    94 Citations
    Highly Influencial Citations
    4
    Background Citations
    37
    Methods Citations
    2
    Results Citations
    1
    94 Citations
    Citation Type

    Citation Type

    Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
    • 633
    Signaling Pathways in Rare Lymphomas
    Identification and functional characterisation of oncogenic pathway signatures in malignant lymphoma
    • Highly Influenced
    Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments.
    • 35
    Burkitt's lymphoma in a young Brazilian boy.
    • 7
    • PDF
    Signaling pathways in lymphoma: pathogenesis and therapeutic
    Burkitt Lymphoma: Pathogenesis and Immune Evasion
    • 37
    • PDF
    Signaling pathways in lymphoma: pathogenesis and therapeutic targets.
    • 12
    E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma.
    • 36
    • Highly Influenced
    • PDF
    Denis Burkitt and the African lymphoma
    • 6
    • PDF

    References

    SHOWING 1-10 OF 70 REFERENCES
    Molecular diagnosis of Burkitt's lymphoma.
    • 815
    • PDF
    A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
    • 892
    • PDF
    Burkitt's lymphoma: clinicopathologic features and differential diagnosis.
    • 295
    • PDF
    Adult Burkitt leukemia and lymphoma.
    • 501
    • PDF
    c‐Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome
    • 69
    Graft versus Burkitt's Lymphoma Effect after Allogeneic Marrow Transplantation
    • 25
    Novel Treatment of Burkitt Lymphoma with Dose-Adjusted EPOCH-Rituximab: Preliminary Results Showing Excellent Outcome.
    • 17
    Clinical, Immunophenotypic, and Genetic Analysis of Adult Lymphomas With Morphologic Features of Burkitt Lymphoma
    • 137
    Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types).
    • 120
    Modified Magrath Regimens for Adults with Burkitt and Burkitt-Like Lymphomas: Preserved Efficacy with Decreased Toxicity
    • 111